JAN 30, 2016 11:05 PM PST

Therapy seeks and destroys prostate cancer in mice

A new therapy uses white blood cells to ferry cancer-killing proteins through the bloodstream. Tests show it virtually eliminates metastatic prostate cancer in mice.

“The therapy is remarkably effective in vivo and shows several advantages, such as no toxicity and getting good results in very low dosages,” says senior author Michael King, professor of biomedical engineering at Cornell University. “It was our wildest dream to completely prevent the spread of prostate cancer. And that’s what happened in this system.”
 
A single dose of the experimental therapy-even delivered very late in the course of the disease-dramatically reduced the number of tumor cells. "This suggests that it may never be too late to help," says Michael King.

Metastasis is the spread of cancer cells from one tumor to other organs of the body, such as the lungs, the liver, the spleen, and the kidneys. While surgery and radiation treat primary tumors, it remains difficult to detect and reach metastatic cancer cells—which makes the treatment of spreading cancer more treacherous and problematic, King says.

Researchers created nano-sized liposomes with a protein that attaches to leukocytes (white blood cells). The liposomes are about one-one hundredth the size of the white blood cells. As the white blood cells travel throughout the bloodstream, the hitchhiking protein kills the tumor cells—leaving the bloodstream free of cancer.

As reported in the study, published in the Journal of Controlled Release, prostate cancer cells were implanted into the prostate of male mice to let the tumors grow. The treatment prevented secondary tumors, and the primary tumor shrunk in size.

While treated mice showed no metastases, the circulating tumor cell count remained greatly reduced but not completely zero, which leads scientists to believe “you don’t have to be perfect in completely eliminating circulating tumor cells to observe a very good outcome,” King says.

Further, the researchers discovered that a single dose of the therapy—even delivered very late in the course of the disease—can substantially reduce the number of tumor cells. “This suggests that it may never be too late to help,” King says.

The National Cancer Institute funded the research.

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
MAR 22, 2021
Clinical & Molecular DX
Good Dog! Man's Best Friend Sniffs Out Prostate Cancer.
MAR 22, 2021
Good Dog! Man's Best Friend Sniffs Out Prostate Cancer.
Trained dogs can spot aggressive prostate cancers by detecting trace amounts of chemical biomarkers in urine samples, sa ...
APR 25, 2021
Genetics & Genomics
How Did the Chernobyl Disaster Affect Human Health?
APR 25, 2021
How Did the Chernobyl Disaster Affect Human Health?
It's been about 35 years since the disaster at the Chernobyl nuclear power plant. Now researchers have investigated whet ...
APR 29, 2021
Cell & Molecular Biology
Cancer Cell Fate Influenced by Dietary Amino Acid
APR 29, 2021
Cancer Cell Fate Influenced by Dietary Amino Acid
This work could one day open up dietary therapeutic options for cancer.
MAY 08, 2021
Cancer
More evidence supports the evils of sugary drinks
MAY 08, 2021
More evidence supports the evils of sugary drinks
New research published online in the journal Gut from researchers at the Washington University School of Medicine i ...
MAY 10, 2021
Cell & Molecular Biology
Getting RNA-Based Medicine Past the Blood-Brain Barrier
MAY 10, 2021
Getting RNA-Based Medicine Past the Blood-Brain Barrier
RNA molecules serve several functions, one of which is to help the cell generate proteins from active genes. It also may ...
MAY 17, 2021
Cancer
Cells at the center of a tumor are more aggressive and spread faster
MAY 17, 2021
Cells at the center of a tumor are more aggressive and spread faster
New research stemming from a collaboration between researchers from the Francis Crick Institute, Royal Marsden, UCL and ...
Loading Comments...